Developments and quality assurance in stem cell transplantation - Data from the German National Registry;Entwicklungen in der hämatopoetischen stammzelltransplantation: Daten des Deutschen Registers für stammzelltransplantationen

Deutsches Arzteblatt

Volumn 103, Issue 37, 2006, Pages

  Ottinger, Hellmut ^a   Müller, Carlheinz ^b   Beelen, Dietrich W ^a   Ehninger, Gerhard ^c   Schmitz, Norbert ^d   Zander, Axel ^e   Schrezenmeier, Hubert ^f  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b ZKRD Zentrales Knochenmarkspender Register für die Bundesrepublik Deutschland   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d St Georg Krankenhaus   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f German Red Cross Blood Transfusion Service Baden Württemberg Hessen and University Hospital Ulm   (Germany)

Author keywords

Hematopoietic stem cell transplantation; Hematopoietic stem cells; National registry; Quality assurance; Stem cell donors

Indexed keywords

IMATINIB;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; GERMANY; HEALTH CARE QUALITY; HUMAN; MEDICAL RECORD; MULTIPLE MYELOMA; MYELODYSPLASIA; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; QUALITY CONTROL; STEM CELL TRANSPLANTATION;

EID: 33750091954     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Bekanntmachungen: Richtlinien zur Transplantation peripherer Blutstammzellen. Erarbeitet vom Wissenschaftlichen Beirat der Bundesärztekammer unter Mitwirkung des Paul-Ehrlich-Institutes. Dtsch Artzebl 1997; 94(23):A1584-92.
2. DRST-Jahresberichte; www.drst.de.
3. Cornelissen JJ, Lowenberg B: Role of allogeneic stem cell transplantation in current treatment of acute myeloid leukemia. Hematology (Am Soc Hematol Educ Program) 2005; 151-5.
4. Radich JP, Olavarria E, Apperley JF: Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia. Hematol Oncol Clin North Am 2004; 18:685-702, x.
5. Apperley J, Carreras E, Gluckman E et al., eds.: The EBMT Handbook: Haematopoietic Stem Cell Transplantation. Paris: European School of Haematology 2004.
6. Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M et al.: Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 2006; 37: 439-49.
7. Gahrton G: Progress in hematopoietic stem.cell transplantation in multiple myeloma. Curr Opin Hematol 2005; 12: 463-70.
8. Gratwohl A, Baldomero H, Schmid O et al.: Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003. Bone Marrow Transplant 2005; 36: 575-90.
9. Gratwohl A, Schmid O, Baldomero H et al.: Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey. Bone Marrow Transplant 2004; 34: 855-75.